Exelixis, Inc. (EXEL)
54.57
+0.49
(+0.91%)
USD |
NASDAQ |
Aug 24, 16:00
54.57
0.00 (0.00%)
After-Hours: 20:00
Exelixis Price to Book Value : 7.366 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 7.300 |
| August 20, 2026 | 7.248 |
| August 19, 2026 | 7.342 |
| August 18, 2026 | 7.170 |
| August 17, 2026 | 7.062 |
| August 14, 2026 | 6.917 |
| August 13, 2026 | 6.832 |
| August 12, 2026 | 6.801 |
| August 11, 2026 | 6.929 |
| August 10, 2026 | 7.149 |
| August 07, 2026 | 7.299 |
| August 06, 2026 | 7.046 |
| August 05, 2026 | 7.654 |
| August 04, 2026 | 7.559 |
| August 03, 2026 | 7.432 |
| July 31, 2026 | 7.158 |
| July 30, 2026 | 7.555 |
| July 29, 2026 | 7.469 |
| July 28, 2026 | 7.628 |
| July 27, 2026 | 7.534 |
| July 24, 2026 | 7.474 |
| July 23, 2026 | 7.512 |
| July 22, 2026 | 7.422 |
| July 21, 2026 | 7.576 |
| July 20, 2026 | 7.496 |
| Date | Value |
|---|---|
| July 17, 2026 | 7.548 |
| July 16, 2026 | 7.516 |
| July 15, 2026 | 7.499 |
| July 14, 2026 | 7.528 |
| July 13, 2026 | 7.565 |
| July 10, 2026 | 7.627 |
| July 09, 2026 | 7.708 |
| July 08, 2026 | 7.574 |
| July 07, 2026 | 7.705 |
| July 06, 2026 | 7.496 |
| July 02, 2026 | 7.539 |
| July 01, 2026 | 7.284 |
| June 30, 2026 | 7.345 |
| June 29, 2026 | 7.114 |
| June 26, 2026 | 7.178 |
| June 25, 2026 | 6.976 |
| June 24, 2026 | 6.929 |
| June 23, 2026 | 6.729 |
| June 22, 2026 | 6.73 |
| June 18, 2026 | 6.803 |
| June 17, 2026 | 6.873 |
| June 16, 2026 | 6.828 |
| June 15, 2026 | 6.946 |
| June 12, 2026 | 6.963 |
| June 11, 2026 | 7.012 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Emergent BioSolutions, Inc. | 0.7768 |
| Madrigal Pharmaceuticals, Inc. | 22.57 |
| United Therapeutics Corp. | 3.421 |
| AbbVie, Inc. | -- |
| Tonix Pharmaceuticals Holding Corp. | 0.9390 |
Price to Book Value Related Metrics
| PE Ratio | 17.14 |
| PS Ratio | 6.059 |
| PEG Ratio | 0.3252 |
| Price to Free Cash Flow | 12.59 |
| Price | 54.57 |
| Earnings Yield | 5.83% |
| Market Cap | 13.58B |
| PEGY Ratio | 0.3252 |
| Operating PE Ratio | 14.88 |
| Normalized PE Ratio | 16.87 |